DNA Script

Biotech · Paris, FR

French life-sciences firm specialising in Enzymatic DNA Synthesis and DNA printing.

Founders

Thomas Ybert (France · ♂) — A polytechnicien with a biotech PhD who worked on industrial biotechnology at Sanofi, Total and Amyris, he co-founded DNA Script to make DNA synthesis fast and cheap using a template-free enzymatic process.
Sylvain Gariel (France · ♂) — A Mines ParisTech and Caltech-trained engineer who co-invented DNA Script's enzymatic DNA synthesis technology, he co-founded the company as COO in 2014 to make DNA synthesis fast and accessible.
Xavier Godron (France · ♂) — An engineer who co-invented DNA Script's enzymatic DNA synthesis platform, he co-founded the company as CTO in 2014 to build the SYNTAX benchtop DNA printer.

Shares the most investors with (number = shared investors):

Date	Round	Amount
Jan 2022	Series C Paris DNA-synthesis firm DNA Script completed a 176.8M euro Series C to commercialise its SYNTAX enzymatic DNA-printing platform.	$176.8M

Tap an investor to see what else they have backed.

Data is community-curated and may be incomplete.